The Market Online graphic with ASX-branded charts and the text "HotCopper Highlights" centred in white.
branded charts and the text "HotCopper Highlights" centred in white.
The Market Online
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Good arvo, and welcome to HotCopper Highlights, I’m Isaac McIntyre. In this weekly segment, we go through all the most viewed and most discussed stocks on Australia’s #1 finance website. (It’s also worth mentioning this is the last Highlights for the year before we return in CY26.) Let’s start with most watched.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

First, Boss Energy (ASX:BOE) has had a tough old week, dumping as much as -29% through Week 51 after telling disappointed shareholders they may have got Honeymoon’s predictions a little wrong back in 2021.

The takeaway is Honeymoon’s uranium is of a lower grade than first reported, is less contiguous, and will be harder to extract. Basically: Ouch.

Also heavily watched through this penultimate CY25 week was Dateline Resources (ASX:DTR), which I know JD has spoken about a lot in this Highlights series. The forum’s darling is back in headlines again on new drill hits; top intercepts from North Pipe reached 62.48 metres at 2.52g/t gold from 25.9 metres.

Electro Optic Systems (ASX:EOS) rounded out the most watched on HotCopper, thanks mostly due to a new remote weapon system order from a North American customer. EOS will walk away with US$21 million for the deal.

And now, for the most discussed through this latest trading week.

Here, Winsome Resources (ASX:WR1) stood out after teaming up with Canada’s Li-FT Power in a merger that will see Winsome hand over Gallinée too.

Elsewhere, ever-watched Telix Pharma (ASX:TLX) drew more HotCopper followers after reporting key progress in its latest ProstACT phase. The company dosed patients in its latest flagship prostate cancer program’s milestone.

And finally, lithium’s revival has helped Liontown (ASX:LTR) back to the fore.

No major news here, really, but with LTR shares now up as much as +174% YTD, it seems like more investors will be watching the stock into CY26.

(JD and I actually spoke about Liontown, PLS Group (ASX:PLS), and the lithium revival at length in our final HotCopper Wire episode of the year, if you’re keen to hear more about where we think the alkali metal is heading.)

That’s HotCopper Highlights, I’m Isaac McIntyre – I’ll catch you in ’26.

Join the discussion. See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

More From The Market Online

KGL Resources jumps 25% on US$300M funding deal

KGL Resources has entered into a US$300 million PMPA to help fund construction and development of…
London

With osteo Phase 3 trial at 50% recruitment, Paradigm Bio inks partnership with University of London

Paradigm Biopharma (ASX:PAR) has this week hit two big items out the park: first of all, hitting 50% recruitment

Terra hits multiple intersections at Southwest SW6 prospect; assays now due in next ~12 weeks

Terra Metals has hit multiple intersections of massive sulphides in drilling at the Southwest SW6 prospect…

Listen: HotCopper Wire Podcast #047 – Maybe just send an email next time, Albo

In this week’s HotCopper Wire episode, Isaac McIntyre and Jonathon Davidson break down (poke holes in) Albo’s national address from 7PM Wednesday, talk